Individualized care central to trial canine oral cancer treatment methodSeptember 10, 2021Dogs diagnosed with a rapidly metastatic form of oral cancer may soon have access to a novel alternative treatment, thanks to a newly launched clinical trial.
SPONSORED CONTENTScience In Every StepFeel confident knowing every step a Librela (bedinvetmab injection) treated dog takes is backed by science + Learn More
Canine lymphoma drug gets full approvalJuly 20, 2021Elanco’s Tanovea product contains the active ingredient rabacfosadine, an acyclic nucleotide phosphonate that kills rapidly growing tumor cells.
Veterinary oncology receives global boostJune 1, 2021Enhancing the global standard of treatment for pets diagnosed with cancer is the goal of WSAVA’s newest committee.
Studies supporting canine cancer prevention, treatment get fundingMay 10, 2021The AKC Canine Health Foundation has announced grants totaling more than $850,000 for 11 projects focused on canine oncology.
Cancer research campaign to match donationsMay 10, 2021Merck, Petco Love, and Blue Buffalo will match contributions up to $100,000 for Morris Animal Foundation’s “Stop Cancer Furever” campaign.
Oral cancer: Not just for older petsApril 19, 2021We generally think of oral cancer as a condition that affects middle-aged and older pets, but there are some types of neoplasia that are more common in young pets.
Cancer misdiagnosis may be common in English bulldogsFebruary 11, 2021Research out of CSU suggests a high B-cell count does not necessarily indicate cancer in English bulldogs, Morris Animal Foundation reports.
Cancer funding improves pets' access to careFebruary 1, 2021Pets battling cancer in the Lone Star State will have improved access to veterinary treatment and care, thanks to a new round of funding.
Blood test streamlines canine cancer detectionDecember 9, 2020Texas A&M has introduced a simplified oncology test that allows for early diagnosis in dogs.
Individualized care central to trial canine osteosarcoma treatment methodNovember 16, 2020Dogs diagnosed with a deadly form of bone cancer may soon have a greater chance of survival, thanks to the expansion of a clinical trial.
